Statistics
Publications
52
Citations
2.8K
H-Index
29
Active since
1996
Meirong Xu is an author at Oregon State University specializing in medicine, pharmacology, and engineering.
Publications per year
1996–2025
52
52
Spectrum and Degree of CDK Drug Interactions Predicts Clinical Performance
Ping Chen, Nathan V. Lee, Wenyue Hu et al. · Molecular Cancer Therapeutics · 2016 · 414 citations
Expanding control of the tumor cell cycle with a CDK2/4/6 inhibitor
Kevin D. Freeman‐Cook, Robert L. Hoffman, Nichol Miller et al. · Cancer Cell · 2021 · 172 citations
Meirong Xu, Anne Bailey, Judith F. Hernaez et al. · Carcinogenesis · 1996 · 140 citations · Full text
1–5 of 52